Anesthetic Management of Rapid Ventricular Response Atrial Fibrillation in an Elderly Woman Using Remifentanil; A Case Report
Journal of Cellular & Molecular Anesthesia,
Vol. 7 No. 1 (2022),
12 March 2022
,
Page 70-73
https://doi.org/10.22037/jcma.v6i4.33514
Abstract
Atrial fibrillation (AF) is the most common cardiac Arrhythmia in all clinical settings. In the setting of atrial fibrillation with rapid ventricular response (AFib with RVR), early rate control (with or without restoration of the sinus rhythm) is the center of management. Several drugs are used for the management of rapid ventricular response AF but the optimal one is unknown yet. In this case report we present an elderly woman undergoing urgent ophthalmic surgery whose rapid ventricular response AF was controlled by Remifentanil.
- Atrial Fibrillation
- Ophthalmic Surgery
- Remifentanil
- Cardiac Arrhythmia
How to Cite
References
2. Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circulation Research.2020;127(1):4-20.
3. Ankichetty S, Nanadhakumar A, Subramanyam R, Venkatraghavan L. Acute atrial fibrillation in emergency surgery: Is it rare? Indian journal of anaesthesia.2011;55(3):287.
4. Bhatt HV, Fischer GW. Atrial fibrillation: pathophysiology and therapeutic options. Journal of cardiothoracic and vascular anesthesia.2015;29(5):1333-40.
5. Elbaridi N, Kaye AD, Choi S, Urman RD. Current concepts of phenylpiperidine derivatives use in the treatment of acute and chronic pain. Pain Physician.2017;20(2S):SE23-SE31.
6. Bayındır S, Gökmen N, Erbayraktar S, Küçükgüçlü S, Yılmaz O, Şahin Ö, et al. Cardioprotective Effects of Remifentanil in a Sympathetic Hyperactivity Model in Rabbits. Turkish Journal of Anaesthesiology and Reanimation.2015;43(4):225.
7. Rewari V, Sinha R, Ramachandran R, Trikha A. Termination of paroxysmal supraventricular tachycardia with remifentanil in a parturient with tachycardia-induced cardiomyopathy. International journal of obstetric anesthesia.2014;23(3):295-6.
8. Luna-Ortiz P, Zarco-Olvera G, Ramírez-Ortega M, Tenorio-López FA, Gutiérrez A, Martínez-Rosas M, et al. Antiarrhythmic and cardioprotective effects of remifentanil in anesthetized dogs. Arch Cardiol Mex.2009;79(3):182-8.
9. Türktan M, Güneş Y, Yaliniz H, Matyar S, Hatipoğlu Z, Güleç E, et al. Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery. Turkish Journal of Medical Sciences.2017;47(5):1403-9.
10. Wong GT, Huang Z, Ji S, Irwin MG. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. Journal of cardiothoracic and vascular anesthesia.2010;24(5):790-6.
- Abstract Viewed: 139 times
- PDF Downloaded: 192 times